"We diagnose, evaluate and treat blood diseases (hematology) and cancer (oncology). Diagnosing and treating blood diseases and cancer can be a complex process. Fortunately, our team has access to a range of options from advanced diagnostic imaging to chemotherapy to support services."

During the past decade, Kadlec Clinic Hematology and Oncology conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 91 clinical trials were completed, i.e. on average, 58% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 60 clinical trials were completed. i.e. 89.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kadlec Clinic Hematology and Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 102 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Novartis Pharmaceuticals" with 15 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kadlec Clinic Hematology and Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 95 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Kadlec Clinic Hematology and Oncology" are "Recurrent Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Kadlec Clinic Hematology and Oncology" in a lesser frequency.

Most popular intervention types in "Kadlec Clinic Hematology and Oncology" are "Drug" (188 trials), "Other" (117 trials), "Biological" (91 trials), "Procedure" (51 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Quality-of-Life Assessment" (47 trials), "Questionnaire Administration" (33 trials), "Biospecimen Collection" (28 trials) and "Computed Tomography" (28 trials). Other intervention names were less common.

The vast majority of trials in "Kadlec Clinic Hematology and Oncology" are 188 trials for "All" genders, 32 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kadlec Clinic Hematology and Oncology". undefined are not yet recruiting, 59 are recruiting, 99 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in Kadlec Clinic Hematology and Oncology, 5 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Kadlec Clinic Hematology and Oncology, 10 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".